Red blood cell and reticulocyte chimerism studies in non-myeloablative allogeneic peripheral blood haematopoietic stem cell transplantation

被引：0
|
作者：
Harritshoj, L [1 ]
Berkowicz, A [1 ]
Petersen, SL [1 ]
Madsen, HO [1 ]
Ryder, LP [1 ]
Vindelov, L [1 ]
Andersen, P [1 ]
Dickmeiss, E [1 ]
机构：
[1] Rigshosp, DK-2100 Copenhagen, Denmark
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S116 / S117
页数：2
相关论文
共 50 条
  • [41] Analysis of chimerism in the early post-transplantation period in cellular subsets of patients undergoing myeloablative (MA) and non-myeloablative (NMA) allogeneic blood stem cell transplantation (BSCT)
    Thiede, C
    Brendel, C
    Mohr, B
    Florek, M
    Oelschlägel, U
    Ritter, M
    Naumann, R
    Geissler, G
    Ehninger, G
    Neubauer, A
    Bornhäuser, M
    BONE MARROW TRANSPLANTATION, 1999, 23 : S50 - S50
  • [42] Non-myeloablative and myeloablative peripheral blood stem cell transplantation: Comparison of post-transplant complications and survival.
    Tzolas, AC
    Devidas, M
    Mina, S
    Cartwright, B
    Salansky, J
    Finiewicz, K
    Moreb, J
    Khan, S
    Wingard, JR
    Reddy, V
    BLOOD, 2001, 98 (11) : 403A - 403A
  • [43] T cell (CD3+) chimerism after non-myeloablative allogeneic hematopoietic stem cell transplantation (NMHSCT)
    Sobecks, R
    Theil, K
    Rybicki, L
    Kuczkowski, E
    Warshawsky, I
    Tubbs, R
    Kalaycio, M
    Pohlman, B
    Andresen, S
    Bolwell, BJ
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 41 - 42
  • [44] Non-myeloablative allogeneic stem cell transplantation for metastatic renal cell carcinoma
    Bahnson, R
    Hu, HS
    Vogelzang, NJ
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2003, 21 (01) : 79 - 81
  • [45] Non-Myeloablative Stem Cell Transplantation
    Robert Marcus
    Bone Marrow Transplantation, 2001, 27 (6) : 667 - 667
  • [46] Optimisation of recombinant human erythropoietin therapy after non-myeloablative allogeneic haematopoietic stem cell transplantation
    Baron, F
    Vanstraelen, G
    Frere, P
    Fillet, G
    Beguin, Y
    BONE MARROW TRANSPLANTATION, 2004, 33 : S111 - S111
  • [47] GVHD and CMV antigenemia after allogeneic peripheral blood stem cell transplantation: Comparison between myeloablative and non-myeloablative (MINI) conditioning regimens.
    Reddy, V
    Pollock, BH
    Sharda, S
    Hopkins, J
    Weeks, F
    Manion, K
    Roque, D
    Leather, HL
    Finiewicz, KJ
    Khan, SA
    Mehta, P
    Moreb, JS
    Wingard, JR
    BLOOD, 2000, 96 (11) : 191A - 191A
  • [48] SUCCESSFUL OUTCOME AFTER NON-MYELOABLATIVE ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH RENAL DYSFUNCTION
    Kersting, S.
    Verdonck, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 141 - 141
  • [49] An improved outcome of acute GVHD following non-myeloablative peripheral blood stem cell transplantation.
    Fahmy, OA
    Mahmoud, HK
    Haddad, A
    El Badawy, S
    Kamel, A
    Sedky, H
    Latif, SA
    Moaty, MA
    Fattah, RA
    Sobhy, A
    Nassar, A
    El Emary, M
    Rabie, T
    Adel, N
    BLOOD, 2001, 98 (11) : 356B - 356B
  • [50] Ethmoidal sinusitis caused by Exserohilum rostratum in a patient with malignant lymphoma after non-myeloablative allogeneic peripheral blood stem cell transplantation
    Togitani, K.
    Kobayashi, M.
    Sakai, M.
    Uemura, Y.
    Taguchi, H.
    Morita, T.
    Sugihara, S.
    Sano, A.
    Nishimura, K.
    TRANSPLANT INFECTIOUS DISEASE, 2007, 9 (02) : 137 - 141
12345